Woodline Partners LP Orchard Therapeutics PLC Transaction History

Woodline Partners LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $253,215 - $546,221	-361,736 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $810,288 - $1.55 Million	361,736 New	361,736 $832,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $247,143 - $407,027	-56,297 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $2.98 Million - $6.17 Million	-679,158 Reduced 92.35%	56,297 $409,000
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $2.19 Million - $2.88 Million	568,546 Added 340.63%	735,455 $3.18 Million
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $515,151 - $808,449	-125,341 Reduced 42.89%	166,909 $686,000
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $1.72 Million - $3.59 Million	-299,000 Reduced 50.57%	292,250 $1.75 Million
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $2.7 Million - $7.52 Million	478,494 Added 424.36%	591,250 $4.45 Million
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $1.14 Million - $1.76 Million	112,756 New	112,756 $1.55 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.